Steven Paul, M.D.

Voyager Therapeutics

Contact Information

Steven Paul, M.D.
Cambridge, United States

Professional Information

President and CEO
Voyager Therapeutics

Education

Financial Disclosure

Member reports the following financial or other potential conflicts of interest:

Now CEO of a private neuroscience gene therapy company , owner of stock. Also former head of R&D at Lilly and also a shareholder of Lilly. Co-inventor of Solanezumab .